Tweden, Katherine S.

Effect of Reversible Intermittent Intra-abdominal Vagal Nerve Blockade on Morbid Obesity: The ReCharge Randomized Clinical Trial

Ikramuddin, S., Blackstone, R. P., Brancatisano, A., Toouli, J., Shah, S. N., Wolfe, B. M., Fujioka, K., Maher, J. W., Swain, J., Que, F. G., et al. (2014) · JAMA

Bariatric Surgery and OutcomesVagus Nerve Stimulation Research

Cited by 214

Two-Year Outcomes of Vagal Nerve Blocking (vBloc) for the Treatment of Obesity in the ReCharge Trial

Apovian, C. M., Shah, S. N., Wolfe, B. M., Ikramuddin, S., Miller, C. J., Tweden, K. S., Billington, C. J., & Shikora, S. A. (2017) · Obesity Surgery

Bariatric Surgery and OutcomesVagus Nerve Stimulation Research

Cited by 145

Sustained Weight Loss with Vagal Nerve Blockade but Not with Sham: 18-Month Results of the ReCharge Trial

Shikora, S. A., Wolfe, B. M., Apovian, C. M., Anvari, M., Sarwer, D. B., Gibbons, R. D., Ikramuddin, S., Miller, C. J., Knudson, M. B., Tweden, K. S., et al. (2015) · Journal of Obesity

Bariatric Surgery and OutcomesVagus Nerve Stimulation Research

Cited by 83

Real-World Safety of an Implantable Continuous Glucose Sensor Over Multiple Cycles of Use: A Post-Market Registry Study

Deiss, D., Irace, C., Carlson, G., Tweden, K. S., & Kaufman, F. R. (2020) · Diabetes Technology & Therapeutics

Diabetes Management and ResearchElectrochemical sensors and biosensors

Cited by 44

Real-World Data from the First U.S. Commercial Users of an Implantable Continuous Glucose Sensor

Sanchez, P., Ghosh-Dastidar, S., Tweden, K. S., & Kaufman, F. R. (2019) · Diabetes Technology & Therapeutics

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 40